Literature DB >> 11259833

The potential use of receptor-mediated endocytosis for oral drug delivery.

G J Russell-Jones1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11259833     DOI： 10.1016/s0169-409x(00)00127-7

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN： 0169-409X            Impact factor:   15.470


× No keyword cloud information.
  16 in total

1.  Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form.

Authors:  K E Anderson; L A Eliot; B R Stevenson; J A Rogers
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

Review 2.  Applications of glycosyltransferases in the site-specific conjugation of biomolecules and the development of a targeted drug delivery system and contrast agents for MRI.

Authors:  Boopathy Ramakrishnan; Elizabeth Boeggeman; Pradman K Qasba
Journal:  Expert Opin Drug Deliv       Date:  2008-02       Impact factor: 6.648

Review 3.  Poly(amido amine) dendrimers in oral delivery.

Authors:  Venkata K Yellepeddi; Hamidreza Ghandehari
Journal:  Tissue Barriers       Date:  2016-04-06

4.  Production of recombinant human growth hormone conjugated with a transcytotic peptide in Pichia pastoris for effective oral protein delivery.

Authors:  Jun-Yeong Lee; Sang-Kee Kang; Hui-Shan Li; Chang-Yun Choi; Tae-Eun Park; Jin-Duck Bok; Seung-Ho Lee; Chong-Su Cho; Yun-Jaie Choi
Journal:  Mol Biotechnol       Date:  2015-05       Impact factor: 2.695

Review 5.  Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRI.

Authors:  Pradman K Qasba; Boopathy Ramakrishnan; Elizabeth Boeggeman
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

Review 6.  Approaches for enhancing oral bioavailability of peptides and proteins.

Authors:  Jwala Renukuntla; Aswani Dutt Vadlapudi; Ashaben Patel; Sai H S Boddu; Ashim K Mitra
Journal:  Int J Pharm       Date:  2013-02-18       Impact factor: 5.875

7.  Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection.

Authors:  Mookkan Prabakaran; Selvaraj Madhan; Nayana Prabhu; Jia Qiang; Jimmy Kwang
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

Review 8.  Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation.

Authors:  Anil Kumar; Fei Chen; Anbu Mozhi; Xu Zhang; Yuanyuan Zhao; Xiangdong Xue; Yanli Hao; Xiaoning Zhang; Paul C Wang; Xing-Jie Liang
Journal:  Nanoscale       Date:  2013-09-21       Impact factor: 7.790

Review 9.  Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.

Authors:  Yeonhee Yun; Yong Woo Cho; Kinam Park
Journal:  Adv Drug Deliv Rev       Date:  2012-11-02       Impact factor: 15.470

10.  Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury.

Authors:  Mandy B Esch; Gretchen J Mahler; Tracy Stokol; Michael L Shuler
Journal:  Lab Chip       Date:  2014-08-21       Impact factor: 6.799
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.